Connect with us

Hi, what are you looking for?

Expo-ETFExpo-ETF

World News

Prince Frederik of Luxembourg dies from rare disease

Prince Frederik of Luxembourg has died after a lifelong battle with a rare genetic disorder known as POLG mitochondrial disease.

He passed away on March 1 in Paris, his family announced on the website of the POLG Foundation, which Frederik started in 2022.

“It is with a very heavy heart that my wife and I would like to inform you of the passing of our son, The POLG Foundation Founder and Creative Director, Frederik,” his father Prince Robert of Luxembourg wrote.

The foundation describes POLG as a “genetic mitochondrial disorder that robs the body’s cells of energy, in turn causing progressive multiple organ dysfunction and failure.”

It said the disease has no treatment or cure.

“Frederik and the POLG Foundation … are committed to finding therapies and a cure to save other patients from suffering what Frederik and our family have endured,” his father wrote.

Prince Frederik died a day after Rare Disease Day. He was in his early 20s.

This post appeared first on cnn.com

You May Also Like

Stock

2025 is off to a rough start for stocks, but there are still some pockets of strength in the market. Year-to-date, SPY is down...

Tech News

The UK has unveiled a punchy new climate goal to slash its emissions by 81% by 2035. The government said it is on a...

Tech News

Social media platform Bluesky says it has gained 700,000 new users in the week following the US election. Bluesky, which was originally conceived as...

Stock

The next step in the stock market will be very interesting. I’ve been discussing a potential Q1 correction since our MarketVision event the first...

Disclaimer: Expo-ETF.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Expo-ETF.com All Rights Reserved.